Lord Prior, Department of Health minister in charge of relations with pharma and Brexit, discusses exiting the EU, the promised UK Life Sciences strategy and the future of pharma pricing.<
The UK government is to launch a new industrial strategy aimed at helping the country thrive post-Brexit, and life sciences will be ‘centre stage’ when it is unveiled in the spring.
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.